{"version":"1.0","provider_name":"Wockhardt","provider_url":"https:\/\/www.wockhardt.com","author_name":"Wockhardt demo","author_url":"https:\/\/www.wockhardt.com\/author\/wockhardt\/","title":"Wockhardt announces successful initiation of Global Phase 3 Clinical Study of its novel antibiotic WCK 5222 (16 Aug 2022) - Wockhardt","type":"rich","width":600,"height":338,"html":"
Wockhardt announces successful initiation of Global Phase 3 Clinical Study of its novel antibiotic WCK 5222 (16 Aug 2022)<\/a><\/blockquote>